Glutathione

The body's master antioxidant, studied for oxidative stress reduction, immune support, liver detoxification, and skin brightening.

Antioxidant Detox Immune Prescription Required

Mechanism of Action

Glutathione is a tripeptide (glutamate, cysteine, glycine) and the body's primary endogenous antioxidant. It neutralizes free radicals, supports Phase II liver detoxification, modulates the immune system, and protects mitochondria from oxidative damage. Levels decline with age, illness, and chronic stress.

Glutathione repletion through physician-supervised protocols has been studied for antioxidant support, immune enhancement, and cellular protection. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.

MechanismBiological Effect
Master antioxidantNeutralizes free radicals, reduces oxidative stress
Phase II detoxificationSupports liver detox pathways, neutralizes toxins
Immune modulationEnhances T-cell function, NK cell activity
Skin brighteningInhibits melanin synthesis, supports even skin tone
Mitochondrial supportProtects mitochondria from oxidative damage
Liver protectionSupports hepatocyte function, heavy metal chelation

Candidate Profile

Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with NAD+ candidates:

Oxidative Stress

Individuals with high oxidative load, chronic illness, or environmental toxin exposure seeking antioxidant support.

Immune Support

Individuals seeking enhanced immune function, reduced inflammation, and pathogen defense support.

Detoxification

Individuals seeking liver support, heavy metal clearance, and Phase II detox pathway optimization.

Skin & Anti-Aging

Individuals targeting melanin regulation, skin luminosity, and oxidative aging reduction.

What the Clinical Literature Indicates

All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.

Weeks 1–2
Acute glutathione repletion. Improved energy and reduced inflammation may be noted early. Individual outcomes vary.
Weeks 2–8
Progressive antioxidant, detox, and immune benefits may emerge with sustained administration. Results vary significantly.
Ongoing
Long-term glutathione support reviewed periodically by your physician. Protocol adjusted based on clinical response.

Your Protocol Package

Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD

Valid prescription — Issued by your attending physician upon protocol approval

Pharmacy-dispensed compound — From our licensed 503A compounding pharmacy partner

Follow-up check-in — Physician review at protocol midpoint; reorder pathway established

Clinical Considerations

Your physician will review your complete health history before determining eligibility.

Liver disease: Glutathione is used in hepatoprotection. Reviewed carefully with advanced liver conditions.
Current medications: Disclose all medications. Interactions reviewed at intake.
Sulfa allergy: Glutathione contains sulfur. Reviewed at intake for sensitivity history.

Common Questions

Is Glutathione FDA-approved? +
This compound is not FDA-approved as a drug. It is dispensed as a compounded medication through licensed 503A compounding pharmacies operating under FDA guidelines. All Verum Health protocols require a valid physician prescription.
What does the consultation involve? +
After completing your HIPAA-secure health intake, a physician or NP will review your medical history, current medications, goals, and contraindications. If you're a candidate, a virtual consultation is scheduled — typically 15–20 minutes. Turnaround is 24–48 hours from intake submission.
Can I combine this with other protocols? +
Protocol stacking is reviewed on a case-by-case basis during your physician consultation. Any combination protocol is evaluated for safety and clinical appropriateness.
How do I reorder? +
Reorders are managed through your patient portal. A follow-up physician check-in is required at protocol completion before continuation is authorized.